Sunday, September 25, 2022
wellness India Expo
Home Tags Antibody

Tag: Antibody

Mathematical model to predict COVID-19 vaccine efficacy

The researchers began by analysing over 80 different neutralising antibodies reported to be generated after vaccination against the surface spike protein of SARS-CoV-2, the virus that causes COVID-19

COVAXIN (BBV152) booster shown to neutralize both Omicron & Delta variants...

100% of test serum samples showed neutralization of the Delta variant and more than 90% of serum samples showed neutralization of the Omicron variant

Roche launches antibody cocktail to treat COVID-19, Cipla to market it...

Casirivimab and Imdevimab is indicated for restricted use in emergency situation for the treatment of mild to moderate COVID-19 in patients who are at high risk of severe COVID-19.............................

Roche gets DCGI nod for its investigational antibody cocktail in India

Casirivimab and Imdevimab is indicated for the treatment of mild to moderate Covid-19 in high-risk patients........................

Roche Diagnostics launches test to measure antibody levels against SARS-CoV-2

The test targets antibodies against the spike protein and plays an important part in characterizing a vaccine-induced immune response..........................

COVID-19: ICGEB-Emory Vaccine Center’s fresh study offers hope to improve plasma therapy...

A new study by the ICGEB-Emory Vaccine Center offers hope to improve plasma therapy regimen in India..................

ICMR approval for HiMedia-Syngene COVID-19 antibody test kit, ELISafe 19

Syngene developed the IgG based ELISA at its research facility in Bengaluru and partnered with HiMedia to manufacture and commercialize the product. HiMedia is seeking approval from the Central Drugs Standard Control Organisation (CDSCO) and will launch the kits once approval is in place...................

COVID-19: Abbott begins supply of IgG based antibody tests to India

Abbott's SARS-CoV-2 IgG test can be used for large-scale antibody testing, in line with the ICMR recommendation for the use of IgG CLIA (Chemiluminescence immunoassay) tests. It has demonstrated reliable results with 99.6% specificity and 100% sensitivity for patients tested 14 days or more after symptoms started...................

Boehringer Ingelheim partners CDR-Life to develop antibody based therapeutics for Geographic...

Together the partners will advance CDR-Life’s preclinical antibody fragments targeting a key pathway in geographic atrophy (GA) besides developing novel treatments and technologies for patients who have only inadequate treatment options........................

Abbott gets CE Mark for its COVID-19 lab-based antibody test in...

Abbott will begin shipping to India by the end of May and will scale up to meet the demands subsequently. The test demonstrated specificity and sensitivity of greater than 99 percent 14 days or more after symptoms started.....................